Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial. Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.
Phototherapy (PT) is widely used and assumed to be safe as well as effective in reducing total bilirubin (TB) levels. Our recent NICHD Network Trial showed that aggressive use of phototherapy reduces neurodevelopmental impairment (NDI), but may increase deaths among ELBW infants. Among ventilator treated infants \<750 g birth weight (BW) (n =696), conservative Bayesian analyses (using a neutral prior probability) identified a 99% (posterior) probability that aggressive phototherapy reduced profound NDI but a 99% probability that it increased deaths relative to conservative phototherapy. The possibility that PT increases deaths among high risk infants is also suggested by the Collaborative Phototherapy trial (performed in the 1970s), the only large RCT in which LBW infants were randomly assigned to receive PT or no PT. The relative risk for death among those randomized to PT relative to those randomized to no PT was 1.32 (0.9-1.82) among all LBW infants and 1.49 (0.93-2.40) among ELBW infants. These findings are consistent with a major increase in mortality but have been ignored because the p was \>0.05, an error often made in ignoring important potential treatment hazards when power is limited. Multiple studies, most performed decades ago in larger infants, found that short on/off cycles of PT (e.g. 15 min on/60 min off, 1 h on/3 h off, or 1 h on/1 h off ) are as effective as uninterrupted PT to reduce TSB. (Cycles with \>6 h off PT do not appear to be as effective as uninterrupted PT). The clinical use of uninterrupted rather than cycled PT appears to be based largely on the assumption that PT is safe for all infants.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
210
Cycled versus continuous phototherapy during the first 2 wks after birth, both administered at bilirubin thresholds used in the NICHD Neonatal Network Phototherapy trial .
University of Alabama at Birmingham School of Medicine - UAB Hospital
Birmingham, Alabama, United States
RECRUITINGStanford University - Lucile Packard Children's Hospital
Palo Alto, California, United States
NOT_YET_RECRUITINGUniversity of Cincinnati College of Medicine - Good Samaritan Hospital
Cincinnati, Ohio, United States
RECRUITINGThe University of Texas Southwestern Medical School - Clements University Hospital
Dallas, Texas, United States
RECRUITINGThe University of Texas Health Science Center at Houston; Memorial Hermann-TMC-NICU
Houston, Texas, United States
RECRUITINGThe University of Texas Health Science Center at San Antonio - University Hospital
San Antonio, Texas, United States
RECRUITINGBrain stem auditory evoked response wave V latency
a measure of transient or permanent bilirubin neurotoxicity
Time frame: 35 wks postmenstrual age or discharge
Peak Total Serum Bilirubin (tsb)
Total serum bilirubin (TSB) measurements will be obtained following a study protocol modeled on standard practice for monitoring TSB in ELBW newborns.
Time frame: 14 days from birth
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.